Lipofectamine RNAiMAX Transfection Reage…

The University of Nebraska Medical Center (UNMC), a state agency operating under the Board of Regents of the University of Nebraska, awarded a purchase order to Life Technologies Corporation for the procurement of Lipofectamine RNAiMAX Transfection Reagent, a molecular biology research chemical. The contract, issued on July 15, 2026, specified delivery of four units of the reagent to UNMC General Supply in Omaha, Nebraska, with an expected delivery date of July 24, 2026. The total contract value is $2,930.88, based on a unit price of $732.72 per each, with payment terms of Net 30 and shipment on a free on board destination basis with freight prepaid.

Life Technologies Corporation, the prime contractor located in Pittsburgh, Pennsylvania, is responsible for fulfilling this purchase order in accordance with the Standard Terms of Purchase established by the University of Nebraska. The contract period spans nine calendar days from issuance through the expected delivery date. This procurement represents a routine research supply acquisition by a state higher education institution for use in molecular and cellular biology applications.